These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 19950185)
1. Requirements for control of B-cell lymphoma by NK cells. Brenner CD; King S; Przewoznik M; Wolters I; Adam C; Bornkamm GW; Busch DH; Röcken M; Mocikat R Eur J Immunol; 2010 Feb; 40(2):494-504. PubMed ID: 19950185 [TBL] [Abstract][Full Text] [Related]
2. Critical role of the NKG2D receptor for NK cell-mediated control and immune escape of B-cell lymphoma. Belting L; Hömberg N; Przewoznik M; Brenner C; Riedel T; Flatley A; Polić B; Busch DH; Röcken M; Mocikat R Eur J Immunol; 2015 Sep; 45(9):2593-601. PubMed ID: 26151313 [TBL] [Abstract][Full Text] [Related]
3. [Expression of NKG2D ligands in multidrug-resistant nasopharyngeal carcinoma cell line CNE2/DDP and their effects on cytotoxicity of natural killer cells]. Mei JZ; Guo KY; Wei HM; Song CY Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):887-9. PubMed ID: 17584663 [TBL] [Abstract][Full Text] [Related]
4. The MHC class I molecule H-2Dp inhibits murine NK cells via the inhibitory receptor Ly49A. Olsson-Alheim MY; Sundbäck J; Kärre K; Sentman CL J Immunol; 1999 Jun; 162(12):7010-4. PubMed ID: 10358142 [TBL] [Abstract][Full Text] [Related]
5. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis]. Guo KY; Mei JZ; Yao KT Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963 [TBL] [Abstract][Full Text] [Related]
6. Ras activation induces expression of Raet1 family NK receptor ligands. Liu XV; Ho SS; Tan JJ; Kamran N; Gasser S J Immunol; 2012 Aug; 189(4):1826-34. PubMed ID: 22798674 [TBL] [Abstract][Full Text] [Related]
7. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Pende D; Rivera P; Marcenaro S; Chang CC; Biassoni R; Conte R; Kubin M; Cosman D; Ferrone S; Moretta L; Moretta A Cancer Res; 2002 Nov; 62(21):6178-86. PubMed ID: 12414645 [TBL] [Abstract][Full Text] [Related]
8. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression. Song H; Kim J; Cosman D; Choi I Cell Immunol; 2006 Jan; 239(1):22-30. PubMed ID: 16630603 [TBL] [Abstract][Full Text] [Related]
9. Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway. Le Maux Chansac B; Missé D; Richon C; Vergnon I; Kubin M; Soria JC; Moretta A; Chouaib S; Mami-Chouaib F Int Immunol; 2008 Jul; 20(7):801-10. PubMed ID: 18441340 [TBL] [Abstract][Full Text] [Related]
10. Imbalance of NKG2D and its inhibitory counterparts: how does tumor escape from innate immunity? Zhang C; Zhang J; Wei H; Tian Z Int Immunopharmacol; 2005 Jul; 5(7-8):1099-111. PubMed ID: 15914316 [TBL] [Abstract][Full Text] [Related]
11. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Radaeva S; Sun R; Jaruga B; Nguyen VT; Tian Z; Gao B Gastroenterology; 2006 Feb; 130(2):435-52. PubMed ID: 16472598 [TBL] [Abstract][Full Text] [Related]
12. NK cell receptor calibration: effects of MHC class I induction on killing by Ly49Ahigh and Ly49Alow NK cells. Olsson-Alheim MY; Salcedo M; Ljunggren HG; Kärre K; Sentman CL J Immunol; 1997 Oct; 159(7):3189-94. PubMed ID: 9317116 [TBL] [Abstract][Full Text] [Related]
13. External and internal calibration of the MHC class I-specific receptor Ly49A on murine natural killer cells. Kåse A; Johansson MH; Olsson-Alheim MY; Kärre K; Höglund P J Immunol; 1998 Dec; 161(11):6133-8. PubMed ID: 9834098 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D. Zhang C; Zhang J; Niu J; Zhou Z; Zhang J; Tian Z Hum Immunol; 2008 Aug; 69(8):490-500. PubMed ID: 18619507 [TBL] [Abstract][Full Text] [Related]
15. H-2 allele-specific protection from NK cell lysis in vitro for lymphoblasts but not tumor targets. Protection mediated by alpha 1/alpha 2 domains. Sentman CL; Olsson MY; Salcedo M; Höglund P; Lendahl U; Käre K J Immunol; 1994 Dec; 153(12):5482-90. PubMed ID: 7989750 [TBL] [Abstract][Full Text] [Related]
16. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475 [TBL] [Abstract][Full Text] [Related]
17. Host MHC class I molecules modulate in vivo expression of a NK cell receptor. Karlhofer FM; Hunziker R; Reichlin A; Margulies DH; Yokoyama WM J Immunol; 1994 Sep; 153(6):2407-16. PubMed ID: 8077656 [TBL] [Abstract][Full Text] [Related]
18. Loss or mismatch of MHC class I is sufficient to trigger NK cell-mediated rejection of resting lymphocytes in vivo - role of KARAP/DAP12-dependent and -independent pathways. Oberg L; Johansson S; Michaëlsson J; Tomasello E; Vivier E; Kärre K; Höglund P Eur J Immunol; 2004 Jun; 34(6):1646-53. PubMed ID: 15162434 [TBL] [Abstract][Full Text] [Related]
19. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Diefenbach A; Jamieson AM; Liu SD; Shastri N; Raulet DH Nat Immunol; 2000 Aug; 1(2):119-26. PubMed ID: 11248803 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells. Ostberg JR; Dayanc BE; Yuan M; Oflazoglu E; Repasky EA J Leukoc Biol; 2007 Nov; 82(5):1322-31. PubMed ID: 17711975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]